Acquisition

CenterWell's major acquisition of MaxHealth adds 82 clinics and 120,000 patients, deepening its hold on Florida's value-based senior care sector.

Enpro's 3.2% dividend hike reflects more than just stability; it's a sign of a successful growth strategy and robust health in key tech sectors.

Disc Medicine's promising EPP drug hits a major roadblock as the FDA seeks more data, delaying hope for patients and setting up a high-stakes trial.

NFL star Shawne Merriman alleges his lender is attempting a hostile takeover of his company, sparking a high-stakes legal battle over corporate control.

A landmark $27.7M deal renames Arizona's iconic arena, but this alumni-led partnership is about more than just basketball—it's building a new future.

A new partnership signals a major shift in the art market, placing scientific conservation at the heart of determining an asset's long-term value.

The offender monitoring firm reversed a $2M loss, posting a $0.5M Q1 profit after focusing on key US states and shedding international assets.

Elanco's founding chairman and innovation head are leaving, marking a pivotal leadership shift as the animal health giant charts its post-spin-off future.

Swedish mining giant Boliden lands a massive €1 billion credit line, signaling strong bank confidence and fueling its expansion after a landmark year.

Industry heavyweight Rick Seehausen takes the helm at Lenders One, a strategic move by Altisource to arm independent lenders for a shifting market.

A new free tool tells you the exact year AI will take your job. We investigate if it's a wake-up call or a new form of digital fear-mongering.

Jasmine Hartin is vindicated as drug and assault charges are dismissed, raising questions about a 'weaponized' legal system in her ongoing public saga.

As Gildan prepares to report its 2025 results, all eyes are on its strong activewear sales, the massive HanesBrands acquisition, and future guidance.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

The pipeline giant's record $20B EBITDA is fueled by traditional energy, while it aggressively expands into renewables to power the digital economy.

STADA and Bio-Thera's new golimumab biosimilar wins European approval, promising to slash healthcare costs and expand treatment access for millions.

Japanese giant's all-cash acquisition of Tri Pointe Homes creates a top-5 U.S. builder, raising questions on affordability and market consolidation.

Capgemini's 2025 results show a strong pivot to AI, with bookings soaring and a €700M plan to reshape its workforce for a new era of tech.

As Guardian Pharmacy Services prepares for a key investor conference, it showcases strong growth while its industry faces a looming crisis. Can its model work?

Weatherford deepens its partnership with TotalEnergies, landing a crucial multi-year deal to support Denmark's offshore energy infrastructure.